No matching items found
SHOWING 131 Results
"At a time where the Omicron variant is rapidly spreading, and where we need to step up vaccination and the administration of boosters, I am particularly pleased with today's authorisation of the Novavax vaccine," said EU chief Ursula von der Leyen.
Omicron infections have so far caused "mild" illness or asymptomatic cases, but the WHO said the data was insufficient to establish the variant's clinical severity.
The National Command and Operation Centre has allowed booster shots for people aged over 30 years because of the spread of the Omicron variant to over 100 countries, including Pakistan.
The health experts said that based on studies and research issued by the World Health Organisation (WHO), it indicates that people who received a booster dose were less infected than those who did not receive the booster dose even if they were exposed to mild symptoms.
"We have found that a sizable population of housewives are unvaccinated, and they socialise and attend weddings without face masks,” Qasim Siraj Soomro, parliamentary secretary health of the Sindh provincial government, said.
Prof. Sarah Gilbert, one of the scientists behind the Oxford-AstraZeneca COVID-19 vaccine, is warning that the next pandemic may more contagious and more lethal unless more money is devoted to research and preparations to fight emerging viral threats.
AstraZeneca also revealed in other findings that its preventative moniclonal antibody treatment, Evusheld, "retains neutralisation activity" against Omicron.
The sultanate also cancelled a previous decision that suspended entry from South Africa, Namibia, Botswana, Zimbabwe, Lesotho, Eswatini and Mozambique.
The new vaccine will be produced and distributed by Hayat Biotech, a JV between G42 and Sinopharm CNBG, while the vaccine will be available to the public as a booster dose starting January 2022 as part of the measures taken to contain the virus spread.
The new US study will include up to 1,420 volunteers ages 18 to 55 to test the updated Omicron-based shots for use as a booster or for primary vaccinations. Researchers will examine the tweaked vaccine’s safety and how it revs up the immune system...
